Who are Bird Rock Bio's investors?

Bird Rock Bio's investors include 5AM Ventures, SR One Capital Management.

How much funding has Bird Rock Bio raised?

Bird Rock Bio has disclosed $12.5M raised across 3 rounds.

Where is Bird Rock Bio headquartered?

Bird Rock Bio is headquartered in La Jolla, US.

Bird Rock Bio

Acquired

La Jolla, US · Delaware corporation · 2 known investors

Find your way into Bird Rock Bio

Acquired by Skye Bioscience August 2023 · $15.6M ($15.6 million) · source ↗

Bird Rock Bio was a La Jolla, CA clinical-stage biopharmaceutical company developing antibody-based drugs targeting GPCRs, including nimacimab, a CB1-receptor antibody for fibrotic and metabolic diseases.

Founders & leadership

Richa NandExecutive

Alan GlicklichExecutive

Mark SaadExecutive

Paul A. GraysonExecutive

Erik KarrerExecutive

Ray StevensNamed on SEC filing

Board

Bradley BolzonBoard director

Simon NebelBoard director

Simeon George inBoard directorFounder & CEO at SR One Capital Management

Allan MarchingtonBoard director

Roel BulthuisBoard director

Andrew J. Schwab in 𝕏Board directorManaging Partner at 5AM Ventures

Investors · 2

5AM VenturesBoston · $100K – $4M

SR One Capital ManagementreportedRedwood Cityvia Simeon J. George · board

Reported raises · per SEC filings

Form D private placements

$12.5M disclosed across 3 rounds · 2014–2016

▶$2.5MraisedJan 2017 · 1 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Simon NebelDirector
Mark SaadExecutive Officer
Simeon GeorgeDirector
Allan MarchingtonDirector
Bradley BolzonDirector
Peppi PresitDirector
Andrew J. SchwabDirector
Paul A. GraysonExecutive Officer, Director
Ray StevensDirector
Alan GlicklichExecutive Officer

Offering amount: $2.5M
Amount sold: $2.5M
First sale: Dec 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5MraisedFeb 2016 · 8 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Peppi PresitDirector
Richa NandExecutive Officer
Bradley BolzonDirector
Ray StevensDirector
Simon NebelDirector
Simeon GeorgeDirector
Alan GlicklichExecutive Officer
Allan MarchingtonDirector
Roel BulthuisDirector
Mark SaadExecutive Officer
Paul A. GraysonExecutive Officer, Director
Andrew J. SchwabDirector

Offering amount: $30M
Amount sold: $5M
First sale: Jan 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5MraisedMar 2014 · 8 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Allan MarchingtonDirector
Simon NebelDirector
Simeon GeorgeDirector
Bradley BolzonDirector
Paul A. GraysonExecutive Officer, Director
Roel BulthuisDirector
Erik KarrerExecutive Officer
Andrew J. SchwabDirector
Peppi PresitDirector
Ray StevensDirector

Offering amount: $15M
Amount sold: $5M
First sale: Mar 2014
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Bird Rock one step closer to acquisition by J&J | BioPharma Divebiopharmadive.com · Jan 2017

Frequently asked questions

What does Bird Rock Bio do?: Bird Rock Bio was a La Jolla, CA clinical-stage biopharmaceutical company developing antibody-based drugs targeting GPCRs, including nimacimab, a CB1-receptor antibody for fibrotic and metabolic diseases.
Who are Bird Rock Bio's investors?: Bird Rock Bio's investors include 5AM Ventures, SR One Capital Management.
How much funding has Bird Rock Bio raised?: Bird Rock Bio has disclosed $12.5M raised across 3 rounds.
Where is Bird Rock Bio headquartered?: Bird Rock Bio is headquartered in La Jolla, US.